Novilla Pharmaceuticals

Novilla Pharmaceuticals is a biopharmaceutical company founded in 2019 in Arlington, Virginia, developing novel topical therapeutics via a proprietary AI algorithm for site-specific drug delivery. Lead candidate NOV-1776 completed clinical trials showing 212% efficacy improvement over standard of care.